ServiceNow Strategic Portfolio Management for Healthcare

This page helps healthcare organisations decide which IT initiatives to fund first, by separating work that regulation makes mandatory from discretionary work and scoring the discretionary items against patient safety, clinical outcomes, compliance and financial impact.

Healthcare Portfolio Challenges

Portfolio decisions in a healthcare organisation have to separate work that regulation makes mandatory from work that is a strategic choice, and then score the discretionary initiatives against patient safety, clinical outcomes, compliance and financial impact. The sections below cover those prioritisation criteria and mandatory gates, regulatory alignment, financial and operational impact, portfolio balancing and stakeholder alignment, then the working routines: turning clinical demand into a portfolio intake, running the portfolio review, keeping benefits that survive go-live, and deciding when to stop an initiative that is already underway.

Investment Prioritisation Criteria

Healthcare organisations often use multi-criteria prioritisation. Does the initiative improve patient safety? Does it improve clinical outcomes? Does it support regulatory compliance? Does it improve financial performance or efficiency? Strategic Portfolio Management allows weighting these criteria based on organisational values. A patient safety initiative might score highest; an efficiency initiative might score lower.

Some criteria are mandatory. An initiative that doesn’t support compliance might be rejected regardless of other benefits. An initiative that creates safety risks might be rejected entirely. SPM should accommodate these mandatory gates alongside weighted scoring of other criteria.

Regulatory and Compliance Alignment

Healthcare operates under regulatory frameworks that affect strategy. Compliance requirements might mandate specific investments: updating medical device software for safety, implementing required security controls or meeting accreditation standards. SPM should ensure that compliance requirements inform portfolio decisions. Investment decisions should explicitly address how they support compliance.

Some initiatives are compliance-driven: they’re required regardless of business case because regulations mandate them. SPM should distinguish these from discretionary investments. Organisations need to know which investments are mandatory versus strategic choices. This distinction helps explain budgets to staff and stakeholders.

Financial and Operational Impact

SPM considers financial impact: cost to implement, ongoing cost to operate, expected benefits. Healthcare organisations often measure benefits in quality improvements, safety gains or operational efficiency rather than revenue. These benefits are real but harder to quantify than commercial metrics. SPM should accommodate healthcare’s unique value drivers.

Operational impact matters: will an initiative require staff retraining? Will it disrupt operations during implementation? Some implementations can be phased to minimize disruption. SPM should consider implementation risk and operational burden alongside financial metrics.

Portfolio Balancing

Healthcare portfolios typically balance multiple types of initiatives: infrastructure investments (keeping systems running), compliance investments (meeting regulatory requirements), clinical improvements (supporting better patient care) and operational efficiency (reducing cost). A portfolio with only clinical initiatives might neglect infrastructure until systems fail. A portfolio with only infrastructure might miss opportunities to improve care. SPM helps achieve balance.

Resource constraints limit how many initiatives can run simultaneously. SPM helps limit work-in-progress, prioritise starts and finishes and allocate people and budget across the portfolio. This discipline prevents overcommitting resources and abandoning half-finished initiatives.

Stakeholder Alignment

Healthcare organisations have diverse stakeholders: clinical leadership prioritises patient care, finance prioritises budget, operations prioritises efficiency, compliance prioritises regulatory adherence. SPM creates a visible process that considers all perspectives. When investment decisions are made, stakeholders should understand the reasoning. This transparency builds confidence even when their priority doesn’t rank highest.

Portfolio governance should include representation from major stakeholder groups. Clinical leaders should have input on clinical initiatives. Finance should review costs. Compliance should verify regulatory alignment. Operations should assess feasibility. Inclusive governance prevents surprises and ensures decisions reflect diverse perspectives.

Healthcare-Specific Considerations

Healthcare SPM differs from commercial settings in several ways. Clinical outcomes matter more than revenue. Regulatory compliance is mandatory rather than discretionary. Staff satisfaction affects recruitment and retention of clinical workers. Public mission drives decisions more than profit. SPM frameworks should reflect these values.

Healthcare organisations might prioritise differently than commercial entities. Initiatives that improve patient care might score highly even if they reduce efficiency. Compliance initiatives might rank high even if they don’t improve other metrics. SPM should reflect organisational values and strategy, not generic commercial models.

Common Pitfalls and Best Practices

A common pitfall is starting too many initiatives simultaneously. Each initiative requires management attention; starting too many overloads leadership and ensures nothing finishes. Best practice is limiting work-in-progress: finish some initiatives before starting new ones. SPM enforces this discipline by making investment tradeoffs visible.

Another pitfall is ignoring compliance requirements until crisis forces action. Best practice is ensuring compliance initiatives are planned and funded. SPM should be explicit about compliance obligations: which initiatives are required for compliance, when must they complete, and what resources do they need?

Turning clinical demand into a portfolio intake

Clinical IT requests rarely arrive neatly. A ward manager asks for a handover tool. A consultant wants a dashboard for a clinic. A compliance officer needs a register that does not yet exist. If each request goes straight into a delivery queue, the portfolio fills with work that was never compared against anything else. An intake step solves this by asking every request the same short set of questions before it earns a place: what decision it supports, who will use it, what it depends on, and what happens if it is not done.

The intake should also show whether a request is discretionary or required. A change that a regulator or an accreditation review will expect is not competing on the same terms as a convenience feature. Keeping those two groups visible in the same portfolio view stops the required work from being crowded out.

A sequence for running the portfolio review

A portfolio review is most useful when it changes at least one decision. It is less useful when it becomes a status recital. The sequence below keeps the discussion on the choices that matter.

1. List every active and proposed initiative with its sponsor, its clinical dependency and its required go-live window.
2. Mark each initiative as required or discretionary, and check that required items have funding and staffing before any discretionary item is discussed.
3. Compare the clinical staff demand across initiatives in the same window, since this is where many portfolios over-commit.
4. Review each active initiative against its agreed outcome, and ask the sponsor what would have to be true to continue.
5. Record each decision with its reason, and note which initiatives are waiting for a dependency rather than a decision.

Benefits that survive go-live

Many clinical IT projects are approved on benefits that nobody tracks after the system goes live. A handover tool may be expected to reduce missed tasks, but nobody records the baseline for missed tasks. A new scheduling feature may be expected to cut waiting, but waiting is measured by a different team with different definitions. The fix is to name a benefit owner at intake, agree the measure and its baseline before delivery starts, and schedule the first review for a period after go-live when the system has settled. Without that discipline the portfolio board will be asked to approve the next project on the strength of a benefit it cannot see.

When to stop an initiative that is already underway

Stopping is often the hardest portfolio decision in healthcare, because the staff who have invested time feel the loss, and the clinical need that prompted the work often remains. A stop decision is easier to defend when the reasons are written down: the outcome has changed, the dependency has gone, the cost to finish exceeds the value, or a better route has appeared. Where the initiative carries a regulatory dependency, the stop decision needs the compliance function’s sign-off, and the organization should show how the requirement will be met by another route. Otherwise a paused compliance item can resurface at the next audit with no owner.

Questions about healthcare portfolio governance

How many initiatives can a clinical IT team run at once?

As many as the people needed at go-live can support. The useful limit is the number of clinical staff who must be released for training and support, not the number of projects on a list. Set that limit with clinical operations, and review it when staffing changes.

Should a required compliance project compete with clinical improvements?

It should be planned and funded first, so it is not dependent on whatever budget remains. Discretionary clinical improvements can then be ranked against each other with the required work already protected.

What counts as evidence that a project is worth continuing?

Progress toward the agreed outcome, tested with the user group, plus a current view of the cost to finish. Plan completion alone is not evidence, because a project can finish on schedule and still miss the outcome.

Who should sit on the portfolio board?

Include clinical leadership with the authority to release staff, finance, compliance and the IT service owner. A board without clinical authority can approve work that clinical operations cannot absorb.

A clearer intake and stop process usually starts with the rules the portfolio board already uses. The strategic portfolio management hub describes the wider design, and the service portfolio rationalization article covers how to sort the existing estate before the intake starts.